| pVACtools: a computational toolkit to identify and visualize cancer neoantigens J Hundal, S Kiwala, J McMichael, CA Miller, H Xia, AT Wollam, CJ Liu, ... Cancer immunology research 8 (3), 409-420, 2020 | 195 | 2020 |
| Best practices for bioinformatic characterization of neoantigens for clinical utility MM Richters, H Xia, KM Campbell, WE Gillanders, OL Griffith, M Griffith Genome medicine 11 (1), 1-21, 2019 | 188 | 2019 |
| Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy C Puig-Saus, B Sennino, S Peng, CL Wang, Z Pan, B Yuen, B Purandare, ... Nature 615 (7953), 697-704, 2023 | 100 | 2023 |
| Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer KC Cotto, YY Feng, A Ramu, M Richters, SL Freshour, ZL Skidmore, H Xia, ... Nature communications 14 (1), 1589, 2023 | 76 | 2023 |
| Computational prediction of MHC anchor locations guides neoantigen identification and prioritization H Xia, J McMichael, M Becker-Hapak, OC Onyeador, R Buchli, E McClain, ... Science immunology 8 (82), eabg2200, 2023 | 21 | 2023 |
| pVACtools: a computational toolkit to identify and visualize cancer neoantigens. Cancer Immunol. Res. 2020; 8: 409–420. doi: 10.1158/2326-6066 J Hundal, S Kiwala, J McMichael, CA Miller, H Xia, AT Wollam, CJ Liu, ... CIR-19-0401, 0 | 7 | |
| pVACtools: a computational toolkit to identify and visualize cancer neoantigens. Cancer Immunol. Res. 8, 409–420 J Hundal, S Kiwala, J McMichael, CA Miller, H Xia, AT Wollam, CJ Liu, ... | 6 | 2020 |
| Abstract NG11: Landscape analysis of neoepitope-specific T-cell responses to immunotherapy C Puig-Saus, B Sennino, B Purandare, D An, B Quach, S Peng, H Xia, ... Cancer Research 80 (16_Supplement), NG11-NG11, 2020 | 3 | 2020 |
| Best practices for bioinformatic characterization of neoantigens for clinical utility. Genome Med. 2019; 11 (1): 56 MM Richters, H Xia, KM Campbell, WE Gillanders, OL Griffith, M Griffith | 3 | |
| Best practices for bioinformatic characterization of neoantigens for clinical utility. Genome Med. 2019; 11: 56 MM Richters, H Xia, KM Campbell, WE Gillanders, OL Griffith, M Griffith | 3 | |
| pVACsplice: Predicting neoantigens from tumor-specific alternative splicing events derived from cis-acting regulatory mutations using whole exome and RNA sequencing data MM Richters, KC Cotto, S Kiwala, H Xia, BM Carreno, GP Dunn, A Ribas, ... Cancer Research 82 (12_Supplement), 1215-1215, 2022 | 1 | 2022 |
| 65. Accurate neoantigen prediction depends on mutation position relative to patient-specific MHC anchor locations H Xia, M Richters, C Ramirez, CP Saus, K Cotto, G Dunn, T Fehniger, ... Cancer Genetics 244, 24-25, 2020 | 1 | 2020 |
| RegTools: Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer KC Cotto, YY Feng, A Ramu, M Richters, SL Freshour, ZL Skidmore, H Xia, ... BioRxiv, 436634, 2018 | 1 | 2018 |
| pVACview: an interactive visualization tool for efficient neoantigen prioritization and selection H Xia, MH Hoang, E Schmidt, S Kiwala, J McMichael, ZL Skidmore, B Fisk, ... Genome medicine 16 (1), 132, 2024 | | 2024 |
| 76. Automating immunogenomic tumor board decision-making for neoantigen cancer vaccine design J Yao, K Singhal, S Kiwala, P Goedegebuure, C Miller, H Xia, M Hoang, ... Cancer Genetics 286, S24, 2024 | | 2024 |
| 11. Developing a robust bioinformatics workflow to support personalized neoantigen vaccine clinical trials K Singhal, S Kiwala, PS Goedegebuure, C Miller, E Schmidt, H Xia, ... Cancer Genetics 286, S4, 2024 | | 2024 |
| Improving Neoantigen Prioritization Methods for Personalized Cancer Vaccines H Xia Washington University in St. Louis, 2023 | | 2023 |
| 123 Landscape analysis of the neoepitope-specific T cell responses in patients with and without clinical benefit from immune checkpoint blockade therapy CP Saus, B Sennino, S Peng, Z Pan, B Yuen, B Purandare, K Jacoby, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| 33. Computational prediction of MHC anchor locations guide neoantigen identification and prioritization H Xia, J McMichael, M Becker-Hapak, OC Onyeador, R Buchli, E McClain, ... Cancer Genetics 268, 11-12, 2022 | | 2022 |
| 111. pVACsplice: Predicting neoantigens from tumor-specific alternative splicing events derived from regulatory mutations M Richters, K Cotto, S Kiwala, H Xia, B Carreno, G Dunn, A Ribas, ... Cancer Genetics 268, 35, 2022 | | 2022 |
